Solmaz Dehghan, Pharm D, PhD
About Solmaz Dehghan, Pharm D, PhD
Solmaz Dehghan, Pharm D, PhD, serves as the Associate Director of Regulatory Affairs, CMC at Kite Pharma. With extensive experience in regulatory affairs and a strong academic background in pharmaceutical sciences, she has contributed to drug development and lifecycle management across various organizations, including Gilead Sciences and the FDA.
Current Role at Kite Pharma
Solmaz Dehghan serves as the Associate Director of Regulatory Affairs, CMC at Kite Pharma. She has held this position since 2021, contributing to the development and regulatory strategies for critical projects. Her role involves providing effective and timely strategies during both the development and post-approval phases of pharmaceutical products.
Previous Experience at Gilead Sciences
Prior to her current role, Solmaz Dehghan worked at Gilead Sciences as a Senior Manager in Regulatory Affairs, CMC for 10 months in 2021. In this position, she was responsible for managing regulatory strategies and ensuring compliance during the critical stages of drug development.
Regulatory Affairs Background at FDA
Solmaz Dehghan has direct regulatory experience from her tenure at the FDA, where she worked as a CMC Reviewer from 2014 to 2016. This experience provided her with insights into regulatory processes, enhancing her ability to navigate complex pharmaceutical projects effectively.
Educational Background in Pharmaceutical Sciences
Solmaz Dehghan earned her Doctor of Philosophy (PhD) in Pharmaceutical Sciences from Mashad University of Medical Sciences, completing her studies from 2006 to 2013. She also studied Pharmaceutics and Immunology as a Visiting Student at Trinity College of Dublin in 2010. Additionally, she holds a Doctor of Pharmacy (PharmD) from Shahid Beheshti University of Medical Sciences, where she studied from 1999 to 2005.
Research Experience at BaseHealth
Before her roles in regulatory affairs, Solmaz Dehghan worked as a Research Scientist at BaseHealth from 2013 to 2014. This position allowed her to apply her knowledge in pharmaceutical sciences to research projects, further enhancing her expertise in the field.